Jefferies Financial Group upgraded shares of DiaSorin (OTCMKTS:DSRLF – Get Rating) from an underperform rating to a hold rating in a research note released on Wednesday, The Fly reports. Jefferies Financial Group also issued estimates for DiaSorin’s Q1 2022 earnings at $1.46 EPS, Q2 2022 earnings at $1.23 EPS, Q3 2022 earnings at $1.10 EPS, […]
/PRNewswire/ The "In-vitro Diagnostics Market - Competitive Analysis, Drivers, Challenges, and Five Force Analysis" report has been added to Technavio s.
/PRNewswire/ The "In-vitro Diagnostics Market - Competitive Analysis, Drivers, Challenges, and Five Force Analysis" report has been added to Technavio s.